胃癌术后教科书式结局影响因素分析及预测模型构建
Analysis of Influencing Factors of Textbook Outcome after Gastric Cancer Surgery and Construction of Predictive Model
摘要: 目的:探讨胃癌根治术后患者获得教科书式结局的影响因素,并构建预测模型。方法:回顾性收集2018年9月至2023年4月安徽医科大学第一附属医院胃肠外科行胃癌根治术的394例患者临床资料,随机分为训练集(315例)和验证集(79例)。通过单因素及多因素Logistic回归分析筛选TO的独立影响因素,并构建Nomogram预测模型,采用受试者工作特征曲线评估模型性能。结果:多因素分析显示,白蛋白 < 35 g/L (OR = 0.240, P < 0.001)、CEA升高(OR = 0.103, P < 0.001)、CA125升高(OR = 0.171, P = 0.012)及肿瘤直径 > 3 cm (OR = 0.413, P = 0.016)为TO的独立危险因素,而肿瘤分期升高为独立保护因素(OR = 1.459, P = 0.002),分析可知该结果系统计学导致的人为假象。基于上述因素构建的Nomogram模型在训练集和验证集中的AUC值分别为0.831和0.812。结论:术前白蛋白水平、CEA、CA125、肿瘤直径及肿瘤分期是胃癌术后TO的独立影响因素,基于此构建的预测模型具有良好的预测效能。
Abstract: Objective: To investigate the factors influencing textbook outcomes of patients with gastric cancer after radical gastrectomy and to construct predictive models. Methods: The clinical data of 394 patients undergoing radical gastrectomy in the Department of Gastrointestinal Surgery of the First Affiliated Hospital of Anhui Medical University from September 2018 to April 2023 were retrospectively collected and randomly divided into training set (315 cases) and validation set (79 cases). The independent influencing factors of textbook outcome were screened by univariate and multivariate Logistic regression analysis, and Nomogram prediction model was constructed. The performance of the model was evaluated by subject operating characteristic curve. Results: Multivariate analysis showed that albumin < 35 g/L (OR = 0.240, P < 0.001), elevated CEA (OR = 0.103, P < 0.001), elevated CA125 (OR = 0.171, P = 0.012) and tumor diameter > 3 cm (OR = 0.413, P = 0.016) were independent risk factors for TO, while elevated tumor stage was an independent protective factor (OR = 1.459, P = 0.002), our analysis reveals that this finding is likely a statistical artifact.. The AUC values of Nomogram model constructed based on above factors are 0.831 and 0.812 in training set and validation set respectively. Conclusion: Preoperative albumin level, CEA, CA125, tumor diameter and tumor stage are independent predictors of TO after gastric cancer surgery. The predictive model based on these predictors has good predictive power.
文章引用:徐卫伟, 余昌俊. 胃癌术后教科书式结局影响因素分析及预测模型构建[J]. 临床医学进展, 2025, 15(11): 1087-1097. https://doi.org/10.12677/acm.2025.15113195

参考文献

[1] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
[2] Yang, P., Huang, W., Xu, Y., Teng, Y. and Shu, P. (2025) Trends and Projections of the Burden of Gastric Cancer in China and G20 Countries: A Comparative Study Based on the Global Burden of Disease Database 2021. International Journal of Surgery, 111, 4854-4865. [Google Scholar] [CrossRef] [PubMed]
[3] Li, Y., Hahn, A.I., Laszkowska, M., Jiang, F., Zauber, A.G. and Leung, W.K. (2024) Global Burden of Young-Onset Gastric Cancer: A Systematic Trend Analysis of the Global Burden of Disease Study 2019. Gastric Cancer, 27, 684-700. [Google Scholar] [CrossRef] [PubMed]
[4] 季加孚, 王宇宸, 肖琪严. 中国胃癌腹腔镜手术临床研究现状[J]. 中华普外科手术学杂志(电子版), 2019, 13(2): 109-113.
[5] 张越, 季刚, 陶凯雄, 等. 加速康复外科模式下腹腔镜与开腹胃癌根治术的临床效果: 基于中国多中心数据分析[J]. 南方医科大学学报, 2021, 41(12): 1828-1834.
[6] 庄元旦, 唐浩然, 尹明柳, 等. 腹腔镜直肠癌根治术后“教科书式结局”的影响因素分析[J]. 腹部外科, 2024, 37(6): 425-430.
[7] 朱麒, 卢新军, 许磊波. 肝细胞癌肝移植的教科书结局: 单中心回顾性研究[J]. 实用器官移植电子杂志, 2024, 12(3): 209-214.
[8] 刘智鹏, 李子沐, 罗宇乐, 等. 胆囊癌根治性目的切除术达到教科书式结局对远期预后影响的全国多中心队列研究[J]. 中华消化外科杂志, 2024, 23(7): 926-933.
[9] Çetinkaya-Hosgör, C., Seika, P., Raakow, J., Kröll, D., Dobrindt, E., Maurer, M., et al. (2023) Textbook Outcome after Gastrectomy for Gastric Cancer Is Associated with Improved Overall and Disease-Free Survival. Journal of Clinical Medicine, 12, Article 5419. [Google Scholar] [CrossRef] [PubMed]
[10] Lin, X., Tan, C., Wu, W., Liang, C., Qian, F., Shi, Y., et al. (2024) Association between Textbook Outcome and Long-Term Survival among Patients Undergoing Curative-Intent Resection of Gastric Cancer. Surgery, 176, 1402-1411. [Google Scholar] [CrossRef] [PubMed]
[11] Chen, J., Lin, G., Chen, Q., Zhong, Q., Liu, Z., Que, S., et al. (2022) Textbook Outcome, Chemotherapy Compliance, and Prognosis after Radical Gastrectomy for Gastric Cancer: A Large Sample Analysis. European Journal of Surgical Oncology, 48, 2141-2148. [Google Scholar] [CrossRef] [PubMed]
[12] Aquina, C.T., Hamad, A., Becerra, A.Z., Cloyd, J.M., Tsung, A., Pawlik, T.M., et al. (2021) Is Textbook Oncologic Outcome a Valid Hospital-Quality Metric after High-Risk Surgical Oncology Procedures? Annals of Surgical Oncology, 28, 8028-8045. [Google Scholar] [CrossRef] [PubMed]
[13] Gotoda, T., Yanagisawa, A., Sasako, M., Ono, H., Nakanishi, Y., Shimoda, T., et al. (2000) Incidence of Lymph Node Metastasis from Early Gastric Cancer: Estimation with a Large Number of Cases at Two Large Centers. Gastric Cancer, 3, 219-225. [Google Scholar] [CrossRef] [PubMed]
[14] 严健亮, 谢泽宇, 景蓉蓉, 等. 基于机器学习利用常规检验指标建立胃癌淋巴结转移预测模型[J]. 实用医学杂志, 2024, 40(6): 844-849.
[15] Dal Cero, M., Román, M., Grande, L., Yarnoz, C., Estremiana, F., Gantxegi, A., et al. (2022) Textbook Outcome and Survival after Gastric Cancer Resection with Curative Intent: A Population-Based Analysis. European Journal of Surgical Oncology, 48, 768-775. [Google Scholar] [CrossRef] [PubMed]
[16] Li, S.S., Udelsman, B.V., Parikh, A., Klempner, S.J., Clark, J.W., Roeland, E.J., et al. (2020) Impact of Postoperative Complication and Completion of Multimodality Therapy on Survival in Patients Undergoing Gastrectomy for Advanced Gastric Cancer. Journal of the American College of Surgeons, 230, 912-924. [Google Scholar] [CrossRef] [PubMed]
[17] 唐逸辉, 黄泽宁, 陈起跃, 等. 教科书式结局对新辅助化疗后行外科治疗的进展期胃癌患者的预后价值[J]. 中华外科杂志, 2024, 62(5): 379-386.
[18] Oh, Y., Kim, M.S., Lee, Y.T., Lee, C.M., Kim, J.H. and Park, S. (2020) Laparoscopic Total Gastrectomy as a Valid Procedure to Treat Gastric Cancer Option Both in Early and Advanced Stage: A Systematic Review and Meta-Analysis. European Journal of Surgical Oncology, 46, 33-43. [Google Scholar] [CrossRef] [PubMed]
[19] Yu, J., Huang, C., Sun, Y., et al. (2019) Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients with Locally Advanced Gastric Cancer. JAMA, 321, 1983-1992.
[20] Caruso, S. and Scatizzi, M. (2022) Laparoscopic Gastrectomy for Gastric Cancer: Has the Time Come for Considered It a Standard Procedure? Surgical Oncology, 40, Article ID: 101699. [Google Scholar] [CrossRef] [PubMed]
[21] 李子禹, 闫超, 李沈. 胃癌围手术期营养治疗中国专家共识(2019版) [J]. 中国实用外科杂志, 2020, 40(2): 145-151.
[22] Seto, Y. (2021) Sarcopenia, Muscle Quality, and Gastric Cancer Surgery. Annals of Gastroenterological Surgery, 5, 402-403. [Google Scholar] [CrossRef] [PubMed]
[23] Shaganti, R., Kumar Godara, S., Kumar Singh, R.R.R., Misra, S. and Kumar, S. (2024) Factors Associated with Anastomotic Leak Following Gastrectomy for Gastric Adenocarcinoma and Its Effect on Long-Term Outcomes. Turkish Journal of Surgery, 40, 111-118. [Google Scholar] [CrossRef] [PubMed]
[24] Mao, M., Wei, X., Sheng, H., Wang, X., Li, X., Liu, Y., et al. (2017) Clinical Significance of Preoperative Albumin and Globulin Ratio in Patients with Gastric Cancer Undergoing Treatment. BioMed Research International, 2017, Article ID: 3083267. [Google Scholar] [CrossRef] [PubMed]
[25] Arroyo, V., García-Martinez, R. and Salvatella, X. (2014) Human Serum Albumin, Systemic Inflammation, and Cirrhosis. Journal of Hepatology, 61, 396-407. [Google Scholar] [CrossRef] [PubMed]
[26] Yamashita, K., Ushiku, H., Katada, N., Hosoda, K., Moriya, H., Mieno, H., et al. (2015) Reduced Preoperative Serum Albumin and Absence of Peritoneal Dissemination May Be Predictive Factors for Long-Term Survival with Advanced Gastric Cancer with Positive Cytology Test. European Journal of Surgical Oncology (EJSO), 41, 1324-1332. [Google Scholar] [CrossRef] [PubMed]
[27] Liu, X., Meng, Q.H., Ye, Y., Hildebrandt, M.A.T., Gu, J. and Wu, X. (2014) Prognostic Significance of Pretreatment Serum Levels of Albumin, LDH and Total Bilirubin in Patients with Non-Metastatic Breast Cancer. Carcinogenesis, 36, 243-248. [Google Scholar] [CrossRef] [PubMed]
[28] Arrieta, O., Michel Ortega, R.M., Villanueva-Rodríguez, G., Serna-Thomé, M.G., Flores-Estrada, D., Diaz-Romero, C., et al. (2010) Association of Nutritional Status and Serum Albumin Levels with Development of Toxicity in Patients with Advanced Non-Small Cell Lung Cancer Treated with Paclitaxel-Cisplatin Chemotherapy: A Prospective Study. BMC Cancer, 10, Article No. 50. [Google Scholar] [CrossRef] [PubMed]
[29] Shibata, C., Nakano, T., Yasumoto, A., Mitamura, A., Sawada, K., Ogawa, H., et al. (2022) Comparison of CEA and CA19-9 as a Predictive Factor for Recurrence after Curative Gastrectomy in Gastric Cancer. BMC Surgery, 22, Article No. 213. [Google Scholar] [CrossRef] [PubMed]
[30] 邵杰, 何露, 邸亚男. 血清肿瘤标志物CEA、CA199、CA125、CA724联合检测在胃癌诊断中的应用价值[J]. 当代医药论丛, 2025, 23(1): 115-118.
[31] 李鹏飞. 胃癌患者CEA、CA19-9、CA72-4、CA125检测的临床意义[D]: [硕士学位论文]. 长春: 吉林大学, 2014.
[32] Tan, Z. (2019) Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review. Medical Science Monitor, 25, 3537-3541. [Google Scholar] [CrossRef] [PubMed]
[33] Chen, Y., Mi, Y., Tan, S., Chen, Y., Liu, S., Lin, S., et al. (2025) Cea-Induced PI3K/AKT Pathway Activation through the Binding of CEA to KRT1 Contributes to Oxaliplatin Resistance in Gastric Cancer. Drug Resistance Updates, 78, Article ID: 101179. [Google Scholar] [CrossRef] [PubMed]
[34] Xiao, X., Gao, B., Pang, S., Wang, Z., Jiang, W., Wang, W., et al. (2023) Tumor Size as a Significant Prognostic Factor in T1 Gastric Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis. BMC Gastroenterology, 23, Article No. 121. [Google Scholar] [CrossRef] [PubMed]